Nutrison Diason Energy HP

A unique tube feed specifically designed for patients with hyperglycaemia

Inpatients are at risk of poor glycaemic control^1,2.

Nutritional support strategies for patients with hyperglycaemia

nutrison diason energy hp launch campaign page3 image2

Enteral tube feeds have been found to produce a more rapid rise in blood glucose levels than a nutritionally equivalent solid meal.

Nutrison Diason Energy HP launch campaign page4 image version 2

Controlling blood glucose levels may improve patient outcomes - patient safety and cost^4,5

Causes of hyperglycaemia

The underlying cause of hyperglycaemia is usually loss of insulin producing cells in the pancreas or development of resistance to insulin

Contributing factors of hyperglycaemia

Missing a dose of diabetic medication, tablets or insulin⁵
New medication or change in medication, e.g. steroids⁵
Overfeeding⁶
Stress - physical (e.g. an injury or surgery), mental or emotional
Infection of illness⁷

Symptoms of hyperglycaemia

nutrison diason energy hp launch campaign page4 image

Patient types at risk of hyperglycaemia

nutrison diason energy hp launch campaign page5 image

The impact of hyperglycaemia^16-18

Managing tube fed patients with hyperglycaemia

Multidisciplinary team approach

nutrison diason energy hp launch campaign page6 image

Goals of dietetic intervention:

Prioritise meeting the patient's nutritional requirements
Monitor carbohydrate intake
Communicate with the multidisciplary team
Switch feeding method - bolus vs continuous
Trying a slower feeding rate
Try a high protein or high fibre tube feed

What are diabetes specific formulas?^16-18

nutrison diason energy hp launch campaign page10 image

Clinical benefits of diabetes specific formulas

nutrison diason energy hp launch campaign page11 image

diabetes-specific-formula-a-systematic-review-and-meta-analysis

publication

internal

Diabetes specific formulas: A systematic review and meta analysis

NA35

false

15 mins

/content/dam/sn/local/gbr/hcp/nutricia-academy/diabetes-banner.jpg

This study aimed to develop a systematic review and meta-analysis of the studies published comparing the metabolic and health benefits of a diabetes specific formula (DSF) high in monounsaturated fatty acids (MUFAs) and standard formulas (STDF) in adult patients with diabetes mellitus (DM) or hyperglycaemia.

sn:SN-Resource-Center/HCP/Conditions/tube-feeding

sn:SN-Resource-Center/HCP/Type/Clinical-Papers

sn:ukie/nutricia/authors/a--sanz-parís
sn:ukie/nutricia/authors/p--matía-martín
sn:ukie/nutricia/authors/a--martín-palmero
sn:ukie/nutricia/authors/c--gomez-candela
sn:ukie/nutricia/authors/m-c--robles

/content/experience-fragments/sn/ukie/nutricia-renew/gb/en_gb/site/academy/tube_feeding/diabetes-specific-formula-a-systematic-review-and-meta-analysis/master

false

A. Sanz-París, P. Matía-Martín, A. Martín-Palmero, C. Gomez-Candela, M.C. Robles

15 mins

A UNIQUE tube feed designed for patients with hyperglycaemia

*Isomaltulose has a slow hydrolysis rate resulting in a reduced glucose and insulin response²⁴

**A mixture of soluble and insoluble fibres to help maintain gut health including gut integrity and bowel function²⁵

CLICK HERE FOR ADDITIONAL PRODUCT INFORMATION

Nutrison Diason Energy HP has been proven to improve glucose levels23

nutrison diason energy hp launch campaign page14 image

World Health Organization, 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia.
Gandy J. 2015. Manual of Dietetic Practice.
Pancorbo-Hidalgo PL, et al. Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit. J Clin Nurs. 2001; 10(4):482-90.
McMahon MM, et al. A.S.P.E.N. clinical guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013; 37(1):23-36. https://aspenjournals.onlinelibrary.wiley.com/doi epdf/10.1177/0148607112452001
Davidson P, et al. Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient. Nutr Clin Pract. 2015; 30(5):652-9.
González Infantino CA, et al. Hyperglycemia and hypoalbuminemia as prognostic mortality factors in patients with enteral feeding. Nutrition. 2013; 29(3):497-501.
Meizoso JP, et al. Admission hyperglycemia is associated with different outcomes after blunt versus penetrating trauma. J Surg Res. 2016; 206(1):83-9.
Honiden S, et al. Metabolic Management during Critical Illness: Glycemic Control in the ICU. Semin Respir Crit Care Med. 2015; 36(6):859-69. https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0035-1565253.pdf
Plummer MP, et al. Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med. 2014; 40(7):973-80.
Umpierrez GE, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002; 87(3):978-82. https://academic.oup.com/jcem/article/87/3/978/2846522
Hwangbo Y, et al. Acute Hyperglycemia Associated with Anti-Cancer Medication. Endocrinol Metab (Seoul). 2017; 32(1):23-9. https://www.e-enm.org/upload/pdf/enm-32-23.pdf
Habib SL, et al. Diabetes and risk of cancer. ISRN Oncology. 2013; 2013:583786.
National Diabetes Audit, 2017.
Lau LH, et al. Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review. J Diabetes Investig. 2019; 10(3):780-92. https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdi.12932
Mi D, et al. Correlation of hyperglycemia with mortality after acute ischemic stroke. Ther Adv Neurol Disord. 2017; 11:1756285617731686. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784549/
Elia M, et al. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care. 2005; 28(9):2267-79. https://care.diabetesjournals.org/content/28/9/2267.long
Ojo O, et al. Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review. Nutrients. 2014; 6(11):5142-52. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245584/
American Diabetes Association. Diabetes Care in the Hospital. Diabetes Care. 2017; 40(Suppl 1).
Sanz-París A, et al. Diabetes-specific formulas high in monounsaturated fatty acids and metabolic outcomes in patients with diabetes or hyperglycaemia. A systematic review and meta-analysis. Clin Nutr. 2020; 39(11):3273-82.
Hamdy O, et al. Differences in resource utilization between patients with diabetes receiving glycemia-targeted specialized nutrition vs standard nutrition formulas in U.S. hospitals. JPEN J Parenter Enteral Nutr. 2014; 38(2 Suppl):86s-91s.
Han YY, et al. The clinical and economic impact of the use of diabetes-specific enteral formula on ICU patients with type 2 diabetes. Clin Nutr. 2017; 36(6):1567-72.
Barazzoni R, et al. Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group. Clin Nutr. 2017; 36(2):355-63.
Lansink M, et al. Improved Glucose Profile in Patients With Type 2 Diabetes With a New, High-Protein, Diabetes-Specific Tube Feed During 4 Hours of Continuous Feeding. JPEN J Parenter Enteral Nutr. 2017; 41(6):968-75.
Lina BAR, et al. Isomaltulose (Palatinose®): a review of biological and toxicological studies. Food and Chemical Toxicology. 2002; 40(10):1375-81.
Green CJ. Fibre in enteral nutrition. Clinical Nutrition. 2001; 20(1):23-39.

Nutrison Diason Energy HP is a Food for Special Medical Purposes for the dietary management of disease related malnutrition in patients with diabetes mellitus and/or hyperglycaemia with higher energy and protein needs, and must be used under medical supervision.

Nutrison High Protein Range

1730-nutricia-n-america-hcp-dr-blackford005

Register to access services and resources to support your patients

Our free Sampling Service to order product samples and have them sent to your patients' homes.
Nutricia Academy - A range of CPD accredited e-learning programmes.
Stay up to date with educational events, the latest scientific research and product updates.